Post-approval studies (Phase 4)Study completedNCT03406000
What this trial is testing
Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL
Who this might be right for
Type I Diabetes Mellitus
Sanofi 170
Showing 20 of 1,327 results